Hill's Prescription Diet y/d Iodine-Restricted Diet for Feline Hyperthyroidism: Efficacy and Limitations

Bottom line.

• Van der Kooij et al. 2014 (J Feline Med Surg 16:491–498; n=225 client-owned cats) demonstrated that an iodine-restricted food (Hill's Prescription Diet y/d) normalized serum TT4 in 56/88 (63.6%) cats at 4 weeks and 51/68 (75%) at 8 weeks; clinical signs improved significantly by week 4 in both previously medicated and newly diagnosed cats.¹
• The fundamental constraint is dietary exclusivity: any dietary iodine exposure — treats, other foods, hunting — will provide sufficient iodine for thyroid hormone synthesis and restore hyperthyroidism. In multi-cat households where strict dietary control is not feasible, this approach is not appropriate.^1,2
• Iodine restriction normalizes TT4 by substrate limitation rather than by blocking thyroid peroxidase; the thyroid adenoma remains in place and TT4 rises rapidly if the diet is discontinued or breached.²
• The 2016 AAFP guidelines endorse iodine-restricted diet as a legitimate treatment option for select cats but note that the practical challenges of exclusivity limit its application.²
• This is a clinician-facing evidence summary. It is not a dietary protocol; confirm appropriateness and feeding instructions against current product labeling and the 2016 AAFP guidelines.

Update context

This update summarizes the evidence base for Hill's Prescription Diet y/d (iodine-restricted) as a dietary management strategy for feline hyperthyroidism, focusing on efficacy data and the critical practical limitation of dietary exclusivity.

Managing a hyperthyroid cat where medication is not feasible?

Get an instant cited answer — no signup needed for your first question. Voyage Clinical Desk brings species-specific evidence, monitoring plans, and dosing guidance to the case in front of you.

Try Voyage Clinical Desk

What the evidence shows

Van der Kooij et al. 2014: the largest clinical study

Van der Kooij, Bečvářová, Meyer, Teske, and Kooistra (2014) conducted a prospective, multicentre, non-controlled, open-label study in 225 client-owned hyperthyroid cats across multiple European practices.¹ The study population included 136 female and 89 male cats (median age 15 years, range 4–21 years); 113 had been on prior antithyroid medication (Group 1) and 112 were newly diagnosed cats not previously treated (Group 2). All cats were transitioned to Hill's Prescription Diet y/d Feline.

TT4 outcomes:

• At week 4: TT4 within reference range in 56/88 (63.6%) cats with available data
• At week 8: TT4 within reference range in 51/68 (75%) cats with available data
• TT4 decrease was statistically significant from week 0 (P<0.0001) and did not change significantly from week 4 to week 8
• No significant difference in outcomes between previously medicated (Group 1) and newly diagnosed (Group 2) cats

Clinical signs: Vomiting, polyuria, polydipsia, hyperactivity, polyphagia, weight loss, hair coat quality, and quality of life all improved significantly (P<0.0001) by week 4.

Renal function: Serum creatinine decreased (P=0.001) from week 0 to week 4, consistent with reduced GFR following restoration of euthyroidism — indicating that renal unmasking occurs with dietary management as well as pharmacological management.

Adverse effects: No adverse effects attributed to the iodine-restricted food were observed.

The study concluded that an iodine-restricted food is a valuable management option that can normalize TT4 and improve clinical signs in hyperthyroid cats within 4 weeks, applicable to both newly diagnosed and previously treated cats.

Mechanism of action: iodine substrate limitation

Hill's Prescription Diet y/d Feline restricts dietary iodine to approximately 0.28 ppm (dry matter), compared to iodine concentrations of 1–10 ppm or higher in standard commercial diets and raw/home-cooked foods.^1,2 The thyroid adenoma responsible for feline hyperthyroidism typically retains sensitivity to iodine availability. By limiting substrate (iodide) for thyroid hormone synthesis, the diet reduces TT4 without pharmacological inhibition of thyroid peroxidase. This is a fundamentally different mechanism from methimazole/carbimazole.

The implication is that TT4 control is entirely dependent on maintaining strict iodine restriction: any dietary breach — treats, other commercial foods, hunting prey, or access to another pet's food — provides sufficient iodine to restore thyroid hormone synthesis and may return the cat to a hyperthyroid state within days to weeks.

Dietary exclusivity: the critical constraint

The clinical utility of iodine-restricted diet is limited primarily by the requirement for absolute dietary exclusivity. In practice, this means:^1,2

• The cat must eat only y/d — no other foods, treats, flavored medications, or supplements unless iodine-free
• Multi-cat households where food separation is not reliably achievable are generally unsuitable
• Outdoor cats with access to prey are unsuitable
• Owner compliance counseling is essential

Palatability is not universally excellent; some cats decline y/d, particularly when transitioning abruptly from a palatable prior diet. Gradual transition over 7–14 days is recommended where feasible.

Position in the treatment algorithm

The 2016 AAFP guidelines acknowledge iodine-restricted diet as a legitimate fourth treatment option alongside radioiodine, surgery, and antithyroid drugs.² The guidelines note that it is particularly appropriate for:

• Cats whose owners cannot administer oral medications reliably
• Cats in single-cat households where exclusive feeding is achievable
• Cats where ongoing medication monitoring (CBC, chemistry) is a compliance concern

It is not appropriate as sole therapy before irreversible treatments, since the response to TT4 reduction (including renal unmasking) should be assessed regardless of treatment modality.

How this fits clinical practice

Iodine-restricted diet occupies a niche rather than mainstream role in hyperthyroid management. The evidence from van der Kooij et al. (2014) demonstrates genuine efficacy — 75% TT4 normalization at 8 weeks — but the real-world constraint is owner adherence to dietary exclusivity. Before recommending this approach, confirm: (1) the cat will accept the diet; (2) feeding of any other food can be completely prevented; (3) the owner understands the mechanism and the consequences of dietary breach; and (4) TT4 monitoring will be performed to confirm control. TT4 monitoring at 4 weeks after diet initiation is essential.

Voyage Clinical Desk

From clinical question to SOAP draft — cited differentials, live dose calculators, owner handouts. Trained on the veterinary canon (Plumb's, Ettinger, JVIM, ACVIM consensus, 50,000+ indexed references). First answer free, no signup.

Open Voyage Clinical Desk

References

1. van der Kooij M, Bečvářová I, Meyer HP, Teske E, Kooistra HS. 2014. Effects of an iodine-restricted food on client-owned cats with hyperthyroidism. J Feline Med Surg 16(6):491–498. https://pubmed.ncbi.nlm.nih.gov/24232246/
2. Carney HC, Ward CR, Bailey SJ, Bruyette D, Dennis S, Ferguson D, Hinc A, Rucinsky AR. 2016. 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism. J Feline Med Surg 18(5):400–416. https://pubmed.ncbi.nlm.nih.gov/27143042/
3. Peterson ME, Kintzer PP, Hurvitz AI. 1988. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 2(3):150–157. https://pubmed.ncbi.nlm.nih.gov/3265728/

Changelog

• 2026-06-28: First published.